Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK2 | Q15119 | 10/20 | 0.42 |
| ▸ | CYP11B2 | P19099 | 2/20 | 0.41 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.40 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | RAB9A | P51151 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | FYN | P06241 | 1/20 | 0.34 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.34 |
| ▸ | PIM1 | P11309 | 1/20 | 0.34 |
| ▸ | PIM3 | Q86V86 | 1/20 | 0.34 |
| ▸ | PIM2 | Q9P1W9 | 1/20 | 0.34 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.33 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.33 |
| ▸ | BRAF | P15056 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21168564 | 0.96 | PDK2 (0.41) | PDK2CYP11B2CHEK1CYP11B1FYN | |
| SCHEMBL21168543 | 0.90 | MEN1 (0.48) | PDK2MEN1RAB9AKMT2AADORA2A | |
| SCHEMBL21168538 | 0.87 | PDK2 (0.40) | PDK2MEN1RAB9AKMT2AADORA2A | |
| SCHEMBL21168536 | 0.86 | MEN1 (0.39) | PDK2MEN1RAB9AKMT2AADORA2A | |
| SCHEMBL23873846 | 0.84 | PDK2 (0.38) | PDK2MEN1RAB9AKMT2AADORA2A | |
| SCHEMBL21168612 | 0.84 | MEN1 (0.46) | MEN1KMT2AADORA2AADORA1 | |
| SCHEMBL17031673 | 0.84 | PDK2 (0.38) | PDK2MEN1RAB9AKMT2AADORA2A | |
| SCHEMBL21168528 | 0.84 | PDK2 (0.45) | PDK2CYP11B2CYP11B1 | |
| SCHEMBL22073950 | 0.83 | PDK2 (0.40) | PDK2MEN1RAB9AKMT2AADORA2A | |
| SCHEMBL21578583 | 0.83 | PDK2 (0.40) | PDK2MEN1RAB9AKMT2AADORA2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230126748-A1 | POLYMER, A COMPOSITION, AND AN ELECTROLUMINESCENT DEVICE | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2023-04-27 | — | — | US | disclosed |
| US-20230126748-A1 | POLYMER, A COMPOSITION, AND AN ELECTROLUMINESCENT DEVICE | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2023-04-27 | — | — | US | disclosed |
| US-11233200-B2 | Condensed cyclic compound, composition including the same, and organic light-emitting device including the condensed cyclic compound | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2022-01-25 | — | — | US | disclosed |
| US-20200212306-A1 | QUANTUM DOT ELECTROLUMINESCENCE DEVICE | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2020-07-02 | — | — | US | disclosed |
| US-20190221746-A1 | CONDENSED CYCLIC COMPOUND, COMPOSITION INCLUDING THE SAME, AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE CONDENSED CYCLIC COMPOUND | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2019-07-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11233200-B2 | Condensed cyclic compound, composition including the same, and organic light-emitting device including the condensed cyclic compound | CRY1, CRY2, MCM4 | PDK2 2534/4885CYP11B2 1099/4885CHEK1 500/4885 |
| US-20190221746-A1 | CONDENSED CYCLIC COMPOUND, COMPOSITION INCLUDING THE SAME, AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE CONDENSED CYCLIC COMPOUND | CRY1, CRY2, MCM4 | PDK2 2534/4885CYP11B2 1099/4885CHEK1 500/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.